nodes	percent_of_prediction	percent_of_DWPC	metapath
Vidarabine—Pentostatin—Floxuridine—stomach cancer	0.326	0.448	CrCrCtD
Vidarabine—Cladribine—Floxuridine—stomach cancer	0.206	0.283	CrCrCtD
Vidarabine—Decitabine—Floxuridine—stomach cancer	0.196	0.269	CrCrCtD
Vidarabine—DPP4—blood vessel—stomach cancer	0.00443	0.0816	CbGeAlD
Vidarabine—ADA—hematopoietic system—stomach cancer	0.00298	0.0549	CbGeAlD
Vidarabine—ADORA2A—hematopoietic system—stomach cancer	0.00271	0.0499	CbGeAlD
Vidarabine—ADK—hematopoietic system—stomach cancer	0.00243	0.0448	CbGeAlD
Vidarabine—DPP4—hematopoietic system—stomach cancer	0.00236	0.0435	CbGeAlD
Vidarabine—DPP4—epithelium—stomach cancer	0.00216	0.0397	CbGeAlD
Vidarabine—ADK—smooth muscle tissue—stomach cancer	0.00214	0.0395	CbGeAlD
Vidarabine—ADA—lymphoid tissue—stomach cancer	0.0021	0.0386	CbGeAlD
Vidarabine—DPP4—smooth muscle tissue—stomach cancer	0.00208	0.0383	CbGeAlD
Vidarabine—ADA—digestive system—stomach cancer	0.00207	0.0382	CbGeAlD
Vidarabine—ADK—pancreas—stomach cancer	0.00198	0.0365	CbGeAlD
Vidarabine—DPP4—pancreas—stomach cancer	0.00192	0.0354	CbGeAlD
Vidarabine—ADA—bone marrow—stomach cancer	0.00191	0.0352	CbGeAlD
Vidarabine—ADORA2A—lymphoid tissue—stomach cancer	0.00191	0.0352	CbGeAlD
Vidarabine—ADK—lymphoid tissue—stomach cancer	0.00171	0.0316	CbGeAlD
Vidarabine—ADA—endocrine gland—stomach cancer	0.00171	0.0315	CbGeAlD
Vidarabine—DPP4—lymphoid tissue—stomach cancer	0.00166	0.0306	CbGeAlD
Vidarabine—DPP4—digestive system—stomach cancer	0.00164	0.0302	CbGeAlD
Vidarabine—ADK—bone marrow—stomach cancer	0.00156	0.0287	CbGeAlD
Vidarabine—ADORA2A—endocrine gland—stomach cancer	0.00156	0.0287	CbGeAlD
Vidarabine—DPP4—bone marrow—stomach cancer	0.00151	0.0279	CbGeAlD
Vidarabine—ADORA2A—liver—stomach cancer	0.0014	0.0259	CbGeAlD
Vidarabine—ADK—endocrine gland—stomach cancer	0.0014	0.0258	CbGeAlD
Vidarabine—DPP4—endocrine gland—stomach cancer	0.00136	0.025	CbGeAlD
Vidarabine—ADK—liver—stomach cancer	0.00126	0.0232	CbGeAlD
Vidarabine—DPP4—liver—stomach cancer	0.00122	0.0225	CbGeAlD
Vidarabine—Adenosine monophosphate—PRKAB1—stomach cancer	0.0012	0.171	CrCbGaD
Vidarabine—Adenosine monophosphate—FBP1—stomach cancer	0.0012	0.171	CrCbGaD
Vidarabine—ADA—lymph node—stomach cancer	0.00118	0.0218	CbGeAlD
Vidarabine—Cytarabine—NT5E—stomach cancer	0.00101	0.143	CrCbGaD
Vidarabine—ADK—lymph node—stomach cancer	0.000967	0.0178	CbGeAlD
Vidarabine—DPP4—lymph node—stomach cancer	0.000937	0.0173	CbGeAlD
Vidarabine—Azacitidine—DNMT1—stomach cancer	0.000812	0.115	CrCbGaD
Vidarabine—Decitabine—DNMT1—stomach cancer	0.000792	0.113	CrCbGaD
Vidarabine—Adenosine monophosphate—PRKAA1—stomach cancer	0.00069	0.0981	CrCbGaD
Vidarabine—Adenosine triphosphate—PRKAA1—stomach cancer	0.000599	0.0851	CrCbGaD
Vidarabine—Glucosamine—MMP9—stomach cancer	0.00044	0.0625	CrCbGaD
Vidarabine—Glucosamine—TNF—stomach cancer	0.000289	0.0411	CrCbGaD
Vidarabine—Bronchospasm—Docetaxel—stomach cancer	0.000276	0.00294	CcSEcCtD
Vidarabine—Back pain—Irinotecan—stomach cancer	0.000274	0.00291	CcSEcCtD
Vidarabine—Bronchospasm—Capecitabine—stomach cancer	0.000267	0.00284	CcSEcCtD
Vidarabine—Abdominal discomfort—Capecitabine—stomach cancer	0.000261	0.00277	CcSEcCtD
Vidarabine—Vision blurred—Fluorouracil—stomach cancer	0.000255	0.00272	CcSEcCtD
Vidarabine—Syncope—Irinotecan—stomach cancer	0.000254	0.0027	CcSEcCtD
Vidarabine—Loss of consciousness—Irinotecan—stomach cancer	0.000249	0.00265	CcSEcCtD
Vidarabine—Cough—Irinotecan—stomach cancer	0.000247	0.00263	CcSEcCtD
Vidarabine—Acute coronary syndrome—Docetaxel—stomach cancer	0.000247	0.00263	CcSEcCtD
Vidarabine—Myocardial infarction—Docetaxel—stomach cancer	0.000245	0.00261	CcSEcCtD
Vidarabine—Hypertension—Irinotecan—stomach cancer	0.000244	0.0026	CcSEcCtD
Vidarabine—Acute coronary syndrome—Capecitabine—stomach cancer	0.000239	0.00254	CcSEcCtD
Vidarabine—Cerebrovascular accident—Methotrexate—stomach cancer	0.000239	0.00254	CcSEcCtD
Vidarabine—Discomfort—Irinotecan—stomach cancer	0.000238	0.00253	CcSEcCtD
Vidarabine—Myocardial infarction—Capecitabine—stomach cancer	0.000238	0.00253	CcSEcCtD
Vidarabine—Convulsion—Fluorouracil—stomach cancer	0.000235	0.0025	CcSEcCtD
Vidarabine—Anaphylactic shock—Irinotecan—stomach cancer	0.000231	0.00246	CcSEcCtD
Vidarabine—Chest pain—Fluorouracil—stomach cancer	0.000231	0.00246	CcSEcCtD
Vidarabine—Discomfort—Fluorouracil—stomach cancer	0.000228	0.00243	CcSEcCtD
Vidarabine—Shock—Irinotecan—stomach cancer	0.000227	0.00242	CcSEcCtD
Vidarabine—Cardiac failure—Epirubicin—stomach cancer	0.000225	0.00239	CcSEcCtD
Vidarabine—Hypoaesthesia—Docetaxel—stomach cancer	0.000224	0.00238	CcSEcCtD
Vidarabine—Cerebrovascular accident—Epirubicin—stomach cancer	0.000224	0.00238	CcSEcCtD
Vidarabine—Hyperhidrosis—Irinotecan—stomach cancer	0.000223	0.00238	CcSEcCtD
Vidarabine—Mood swings—Methotrexate—stomach cancer	0.000222	0.00236	CcSEcCtD
Vidarabine—Bradycardia—Capecitabine—stomach cancer	0.000222	0.00236	CcSEcCtD
Vidarabine—Anaphylactic shock—Fluorouracil—stomach cancer	0.000221	0.00235	CcSEcCtD
Vidarabine—Hypoaesthesia—Capecitabine—stomach cancer	0.000217	0.0023	CcSEcCtD
Vidarabine—Tachycardia—Fluorouracil—stomach cancer	0.000216	0.0023	CcSEcCtD
Vidarabine—Hypotension—Irinotecan—stomach cancer	0.000216	0.0023	CcSEcCtD
Vidarabine—Affect lability—Epirubicin—stomach cancer	0.000216	0.00229	CcSEcCtD
Vidarabine—Cardiac disorder—Docetaxel—stomach cancer	0.000209	0.00222	CcSEcCtD
Vidarabine—Flushing—Docetaxel—stomach cancer	0.000209	0.00222	CcSEcCtD
Vidarabine—Cardiac arrest—Epirubicin—stomach cancer	0.000208	0.00222	CcSEcCtD
Vidarabine—Cardiac failure—Doxorubicin—stomach cancer	0.000208	0.00221	CcSEcCtD
Vidarabine—Mood swings—Epirubicin—stomach cancer	0.000208	0.00221	CcSEcCtD
Vidarabine—Paraesthesia—Irinotecan—stomach cancer	0.000207	0.00221	CcSEcCtD
Vidarabine—Cerebrovascular accident—Doxorubicin—stomach cancer	0.000207	0.0022	CcSEcCtD
Vidarabine—Hypotension—Fluorouracil—stomach cancer	0.000207	0.0022	CcSEcCtD
Vidarabine—Dyspnoea—Irinotecan—stomach cancer	0.000206	0.00219	CcSEcCtD
Vidarabine—Somnolence—Irinotecan—stomach cancer	0.000205	0.00218	CcSEcCtD
Vidarabine—Tinnitus—Capecitabine—stomach cancer	0.000203	0.00216	CcSEcCtD
Vidarabine—Mediastinal disorder—Docetaxel—stomach cancer	0.000203	0.00215	CcSEcCtD
Vidarabine—Flushing—Capecitabine—stomach cancer	0.000202	0.00215	CcSEcCtD
Vidarabine—Cardiac disorder—Capecitabine—stomach cancer	0.000202	0.00215	CcSEcCtD
Vidarabine—Musculoskeletal discomfort—Fluorouracil—stomach cancer	0.000202	0.00214	CcSEcCtD
Vidarabine—Arrhythmia—Docetaxel—stomach cancer	0.000201	0.00214	CcSEcCtD
Vidarabine—Affect lability—Doxorubicin—stomach cancer	0.0002	0.00212	CcSEcCtD
Vidarabine—Paraesthesia—Fluorouracil—stomach cancer	0.000199	0.00211	CcSEcCtD
Vidarabine—Pain—Irinotecan—stomach cancer	0.000198	0.0021	CcSEcCtD
Vidarabine—Dyspnoea—Fluorouracil—stomach cancer	0.000197	0.0021	CcSEcCtD
Vidarabine—Somnolence—Fluorouracil—stomach cancer	0.000197	0.00209	CcSEcCtD
Vidarabine—Mediastinal disorder—Capecitabine—stomach cancer	0.000196	0.00209	CcSEcCtD
Vidarabine—Arrhythmia—Capecitabine—stomach cancer	0.000194	0.00207	CcSEcCtD
Vidarabine—Abdominal discomfort—Methotrexate—stomach cancer	0.000194	0.00206	CcSEcCtD
Vidarabine—Cardiac arrest—Doxorubicin—stomach cancer	0.000193	0.00205	CcSEcCtD
Vidarabine—Mood swings—Doxorubicin—stomach cancer	0.000192	0.00204	CcSEcCtD
Vidarabine—Dysgeusia—Docetaxel—stomach cancer	0.000192	0.00204	CcSEcCtD
Vidarabine—Back pain—Docetaxel—stomach cancer	0.000189	0.00201	CcSEcCtD
Vidarabine—Pain—Fluorouracil—stomach cancer	0.000189	0.00201	CcSEcCtD
Vidarabine—Dysgeusia—Capecitabine—stomach cancer	0.000185	0.00197	CcSEcCtD
Vidarabine—Back pain—Capecitabine—stomach cancer	0.000183	0.00195	CcSEcCtD
Vidarabine—Drowsiness—Methotrexate—stomach cancer	0.00018	0.00192	CcSEcCtD
Vidarabine—Vision blurred—Capecitabine—stomach cancer	0.000179	0.0019	CcSEcCtD
Vidarabine—Tremor—Capecitabine—stomach cancer	0.000177	0.00189	CcSEcCtD
Vidarabine—Urticaria—Fluorouracil—stomach cancer	0.000176	0.00187	CcSEcCtD
Vidarabine—Syncope—Docetaxel—stomach cancer	0.000175	0.00187	CcSEcCtD
Vidarabine—Pollakiuria—Epirubicin—stomach cancer	0.000175	0.00186	CcSEcCtD
Vidarabine—Sweating—Methotrexate—stomach cancer	0.000173	0.00184	CcSEcCtD
Vidarabine—Palpitations—Docetaxel—stomach cancer	0.000173	0.00184	CcSEcCtD
Vidarabine—Loss of consciousness—Docetaxel—stomach cancer	0.000172	0.00183	CcSEcCtD
Vidarabine—Cough—Docetaxel—stomach cancer	0.000171	0.00182	CcSEcCtD
Vidarabine—Hypersensitivity—Irinotecan—stomach cancer	0.00017	0.00181	CcSEcCtD
Vidarabine—Syncope—Capecitabine—stomach cancer	0.00017	0.00181	CcSEcCtD
Vidarabine—Convulsion—Docetaxel—stomach cancer	0.00017	0.0018	CcSEcCtD
Vidarabine—Hypertension—Docetaxel—stomach cancer	0.000169	0.0018	CcSEcCtD
Vidarabine—Drowsiness—Epirubicin—stomach cancer	0.000169	0.0018	CcSEcCtD
Vidarabine—Palpitations—Capecitabine—stomach cancer	0.000167	0.00178	CcSEcCtD
Vidarabine—Chest pain—Docetaxel—stomach cancer	0.000167	0.00177	CcSEcCtD
Vidarabine—Loss of consciousness—Capecitabine—stomach cancer	0.000166	0.00177	CcSEcCtD
Vidarabine—Asthenia—Irinotecan—stomach cancer	0.000166	0.00176	CcSEcCtD
Vidarabine—Cough—Capecitabine—stomach cancer	0.000165	0.00176	CcSEcCtD
Vidarabine—Hypertension—Capecitabine—stomach cancer	0.000164	0.00174	CcSEcCtD
Vidarabine—Hypersensitivity—Fluorouracil—stomach cancer	0.000163	0.00173	CcSEcCtD
Vidarabine—Dry mouth—Docetaxel—stomach cancer	0.000163	0.00173	CcSEcCtD
Vidarabine—Sweating—Epirubicin—stomach cancer	0.000162	0.00172	CcSEcCtD
Vidarabine—Pollakiuria—Doxorubicin—stomach cancer	0.000162	0.00172	CcSEcCtD
Vidarabine—Chest pain—Capecitabine—stomach cancer	0.000161	0.00172	CcSEcCtD
Vidarabine—Anxiety—Capecitabine—stomach cancer	0.000161	0.00171	CcSEcCtD
Vidarabine—Anaphylactic shock—Docetaxel—stomach cancer	0.00016	0.0017	CcSEcCtD
Vidarabine—Discomfort—Capecitabine—stomach cancer	0.000159	0.0017	CcSEcCtD
Vidarabine—Dry mouth—Capecitabine—stomach cancer	0.000158	0.00168	CcSEcCtD
Vidarabine—Shock—Docetaxel—stomach cancer	0.000157	0.00167	CcSEcCtD
Vidarabine—Drowsiness—Doxorubicin—stomach cancer	0.000156	0.00166	CcSEcCtD
Vidarabine—Tachycardia—Docetaxel—stomach cancer	0.000156	0.00166	CcSEcCtD
Vidarabine—Bradycardia—Epirubicin—stomach cancer	0.000154	0.00164	CcSEcCtD
Vidarabine—Dizziness—Irinotecan—stomach cancer	0.000153	0.00162	CcSEcCtD
Vidarabine—Shock—Capecitabine—stomach cancer	0.000152	0.00162	CcSEcCtD
Vidarabine—Tinnitus—Methotrexate—stomach cancer	0.000151	0.00161	CcSEcCtD
Vidarabine—Tachycardia—Capecitabine—stomach cancer	0.000151	0.00161	CcSEcCtD
Vidarabine—Hypoaesthesia—Epirubicin—stomach cancer	0.000151	0.0016	CcSEcCtD
Vidarabine—Cardiac disorder—Methotrexate—stomach cancer	0.00015	0.0016	CcSEcCtD
Vidarabine—Sweating—Doxorubicin—stomach cancer	0.00015	0.00159	CcSEcCtD
Vidarabine—Hyperhidrosis—Capecitabine—stomach cancer	0.000149	0.00159	CcSEcCtD
Vidarabine—Hypotension—Docetaxel—stomach cancer	0.000149	0.00159	CcSEcCtD
Vidarabine—Vomiting—Irinotecan—stomach cancer	0.000147	0.00156	CcSEcCtD
Vidarabine—Dizziness—Fluorouracil—stomach cancer	0.000146	0.00156	CcSEcCtD
Vidarabine—Mediastinal disorder—Methotrexate—stomach cancer	0.000146	0.00155	CcSEcCtD
Vidarabine—Rash—Irinotecan—stomach cancer	0.000146	0.00155	CcSEcCtD
Vidarabine—Dermatitis—Irinotecan—stomach cancer	0.000146	0.00155	CcSEcCtD
Vidarabine—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000145	0.00155	CcSEcCtD
Vidarabine—Headache—Irinotecan—stomach cancer	0.000145	0.00154	CcSEcCtD
Vidarabine—Hypotension—Capecitabine—stomach cancer	0.000144	0.00154	CcSEcCtD
Vidarabine—Paraesthesia—Docetaxel—stomach cancer	0.000143	0.00153	CcSEcCtD
Vidarabine—Bradycardia—Doxorubicin—stomach cancer	0.000143	0.00152	CcSEcCtD
Vidarabine—Dyspnoea—Docetaxel—stomach cancer	0.000142	0.00151	CcSEcCtD
Vidarabine—Somnolence—Docetaxel—stomach cancer	0.000142	0.00151	CcSEcCtD
Vidarabine—Tinnitus—Epirubicin—stomach cancer	0.000141	0.0015	CcSEcCtD
Vidarabine—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000141	0.0015	CcSEcCtD
Vidarabine—Cardiac disorder—Epirubicin—stomach cancer	0.000141	0.0015	CcSEcCtD
Vidarabine—Flushing—Epirubicin—stomach cancer	0.000141	0.0015	CcSEcCtD
Vidarabine—Vomiting—Fluorouracil—stomach cancer	0.000141	0.0015	CcSEcCtD
Vidarabine—Hypoaesthesia—Doxorubicin—stomach cancer	0.00014	0.00148	CcSEcCtD
Vidarabine—Rash—Fluorouracil—stomach cancer	0.000139	0.00148	CcSEcCtD
Vidarabine—Dermatitis—Fluorouracil—stomach cancer	0.000139	0.00148	CcSEcCtD
Vidarabine—Paraesthesia—Capecitabine—stomach cancer	0.000139	0.00148	CcSEcCtD
Vidarabine—Headache—Fluorouracil—stomach cancer	0.000139	0.00147	CcSEcCtD
Vidarabine—Dysgeusia—Methotrexate—stomach cancer	0.000138	0.00147	CcSEcCtD
Vidarabine—Dyspnoea—Capecitabine—stomach cancer	0.000138	0.00147	CcSEcCtD
Vidarabine—Nausea—Irinotecan—stomach cancer	0.000137	0.00146	CcSEcCtD
Vidarabine—Mediastinal disorder—Epirubicin—stomach cancer	0.000137	0.00145	CcSEcCtD
Vidarabine—ADK—Metabolism—UMPS—stomach cancer	0.000137	0.00118	CbGpPWpGaD
Vidarabine—ADORA2A—GPCRs, Class A Rhodopsin-like—AGTR2—stomach cancer	0.000137	0.00118	CbGpPWpGaD
Vidarabine—Pain—Docetaxel—stomach cancer	0.000137	0.00145	CcSEcCtD
Vidarabine—Back pain—Methotrexate—stomach cancer	0.000136	0.00145	CcSEcCtD
Vidarabine—DPP4—Metabolism of proteins—IGFBP3—stomach cancer	0.000136	0.00117	CbGpPWpGaD
Vidarabine—Arrhythmia—Epirubicin—stomach cancer	0.000135	0.00144	CcSEcCtD
Vidarabine—ADORA2A—GPCRs, Class A Rhodopsin-like—F2R—stomach cancer	0.000135	0.00116	CbGpPWpGaD
Vidarabine—ADA—Circadian rythm related genes—PPARG—stomach cancer	0.000134	0.00115	CbGpPWpGaD
Vidarabine—ADA—Metabolism—PGLS—stomach cancer	0.000134	0.00115	CbGpPWpGaD
Vidarabine—ADA—Metabolism—BLVRB—stomach cancer	0.000134	0.00115	CbGpPWpGaD
Vidarabine—Vision blurred—Methotrexate—stomach cancer	0.000133	0.00141	CcSEcCtD
Vidarabine—Pain—Capecitabine—stomach cancer	0.000132	0.00141	CcSEcCtD
Vidarabine—ADORA2A—GPCRs, Class A Rhodopsin-like—HTR1A—stomach cancer	0.000131	0.00113	CbGpPWpGaD
Vidarabine—Nausea—Fluorouracil—stomach cancer	0.000131	0.0014	CcSEcCtD
Vidarabine—Tinnitus—Doxorubicin—stomach cancer	0.000131	0.00139	CcSEcCtD
Vidarabine—Flushing—Doxorubicin—stomach cancer	0.00013	0.00138	CcSEcCtD
Vidarabine—Cardiac disorder—Doxorubicin—stomach cancer	0.00013	0.00138	CcSEcCtD
Vidarabine—Tension—Epirubicin—stomach cancer	0.000129	0.00138	CcSEcCtD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—HBEGF—stomach cancer	0.000129	0.00111	CbGpPWpGaD
Vidarabine—Dysgeusia—Epirubicin—stomach cancer	0.000129	0.00137	CcSEcCtD
Vidarabine—Nervousness—Epirubicin—stomach cancer	0.000128	0.00136	CcSEcCtD
Vidarabine—ADA—Metabolism—PPAP2A—stomach cancer	0.000128	0.0011	CbGpPWpGaD
Vidarabine—Back pain—Epirubicin—stomach cancer	0.000128	0.00136	CcSEcCtD
Vidarabine—DPP4—Metabolism of proteins—RPS19—stomach cancer	0.000127	0.0011	CbGpPWpGaD
Vidarabine—ADK—Metabolism—ECHS1—stomach cancer	0.000127	0.00109	CbGpPWpGaD
Vidarabine—ADK—Metabolism—PDHA1—stomach cancer	0.000127	0.00109	CbGpPWpGaD
Vidarabine—Mediastinal disorder—Doxorubicin—stomach cancer	0.000126	0.00134	CcSEcCtD
Vidarabine—DPP4—Metabolism of proteins—PAX6—stomach cancer	0.000126	0.00108	CbGpPWpGaD
Vidarabine—Arrhythmia—Doxorubicin—stomach cancer	0.000125	0.00133	CcSEcCtD
Vidarabine—Vision blurred—Epirubicin—stomach cancer	0.000124	0.00132	CcSEcCtD
Vidarabine—Cough—Methotrexate—stomach cancer	0.000123	0.00131	CcSEcCtD
Vidarabine—ADORA2A—GPCRs, Class A Rhodopsin-like—ADRB1—stomach cancer	0.000123	0.00106	CbGpPWpGaD
Vidarabine—Urticaria—Capecitabine—stomach cancer	0.000123	0.00131	CcSEcCtD
Vidarabine—Convulsion—Methotrexate—stomach cancer	0.000122	0.0013	CcSEcCtD
Vidarabine—Agitation—Epirubicin—stomach cancer	0.000121	0.00129	CcSEcCtD
Vidarabine—ADA—Circadian rythm related genes—SERPINE1—stomach cancer	0.000121	0.00104	CbGpPWpGaD
Vidarabine—ADA—C-MYB transcription factor network—HRAS—stomach cancer	0.000121	0.00104	CbGpPWpGaD
Vidarabine—Chest pain—Methotrexate—stomach cancer	0.00012	0.00128	CcSEcCtD
Vidarabine—ADORA2A—GPCR downstream signaling—KISS1R—stomach cancer	0.00012	0.00103	CbGpPWpGaD
Vidarabine—Tension—Doxorubicin—stomach cancer	0.00012	0.00127	CcSEcCtD
Vidarabine—Dysgeusia—Doxorubicin—stomach cancer	0.00012	0.00127	CcSEcCtD
Vidarabine—ADK—Metabolism—TYMP—stomach cancer	0.000119	0.00103	CbGpPWpGaD
Vidarabine—ADK—Metabolism—FADS1—stomach cancer	0.000119	0.00103	CbGpPWpGaD
Vidarabine—Discomfort—Methotrexate—stomach cancer	0.000119	0.00126	CcSEcCtD
Vidarabine—Nervousness—Doxorubicin—stomach cancer	0.000119	0.00126	CcSEcCtD
Vidarabine—Syncope—Epirubicin—stomach cancer	0.000118	0.00126	CcSEcCtD
Vidarabine—Back pain—Doxorubicin—stomach cancer	0.000118	0.00126	CcSEcCtD
Vidarabine—Hypersensitivity—Docetaxel—stomach cancer	0.000118	0.00125	CcSEcCtD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—AGTR2—stomach cancer	0.000117	0.00101	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—PPP2R1A—stomach cancer	0.000117	0.00101	CbGpPWpGaD
Vidarabine—Palpitations—Epirubicin—stomach cancer	0.000117	0.00124	CcSEcCtD
Vidarabine—Loss of consciousness—Epirubicin—stomach cancer	0.000116	0.00123	CcSEcCtD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—F2R—stomach cancer	0.000116	0.000996	CbGpPWpGaD
Vidarabine—Cough—Epirubicin—stomach cancer	0.000115	0.00123	CcSEcCtD
Vidarabine—Anaphylactic shock—Methotrexate—stomach cancer	0.000115	0.00122	CcSEcCtD
Vidarabine—Vision blurred—Doxorubicin—stomach cancer	0.000115	0.00122	CcSEcCtD
Vidarabine—Asthenia—Docetaxel—stomach cancer	0.000115	0.00122	CcSEcCtD
Vidarabine—Convulsion—Epirubicin—stomach cancer	0.000114	0.00122	CcSEcCtD
Vidarabine—Hypertension—Epirubicin—stomach cancer	0.000114	0.00121	CcSEcCtD
Vidarabine—ADA—Metabolism—CKB—stomach cancer	0.000114	0.000981	CbGpPWpGaD
Vidarabine—ADA—Metabolism—NDUFA2—stomach cancer	0.000114	0.000981	CbGpPWpGaD
Vidarabine—ADA—Metabolism—CA1—stomach cancer	0.000114	0.000981	CbGpPWpGaD
Vidarabine—ADA—Metabolism—FBP1—stomach cancer	0.000114	0.000981	CbGpPWpGaD
Vidarabine—Hypersensitivity—Capecitabine—stomach cancer	0.000114	0.00121	CcSEcCtD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—HTR1A—stomach cancer	0.000113	0.00097	CbGpPWpGaD
Vidarabine—DPP4—Metabolism of proteins—RPS6—stomach cancer	0.000113	0.000969	CbGpPWpGaD
Vidarabine—Chest pain—Epirubicin—stomach cancer	0.000112	0.0012	CcSEcCtD
Vidarabine—Agitation—Doxorubicin—stomach cancer	0.000112	0.00119	CcSEcCtD
Vidarabine—Anxiety—Epirubicin—stomach cancer	0.000112	0.00119	CcSEcCtD
Vidarabine—ADK—Metabolism—SREBF2—stomach cancer	0.000112	0.000963	CbGpPWpGaD
Vidarabine—DPP4—Metabolism of proteins—ACE—stomach cancer	0.000112	0.000962	CbGpPWpGaD
Vidarabine—Hyperhidrosis—Methotrexate—stomach cancer	0.000111	0.00118	CcSEcCtD
Vidarabine—Discomfort—Epirubicin—stomach cancer	0.000111	0.00118	CcSEcCtD
Vidarabine—Asthenia—Capecitabine—stomach cancer	0.000111	0.00118	CcSEcCtD
Vidarabine—ADK—Metabolism—RORA—stomach cancer	0.00011	0.000951	CbGpPWpGaD
Vidarabine—Dry mouth—Epirubicin—stomach cancer	0.00011	0.00117	CcSEcCtD
Vidarabine—Syncope—Doxorubicin—stomach cancer	0.000109	0.00116	CcSEcCtD
Vidarabine—ADORA2A—Signaling by GPCR—KISS1R—stomach cancer	0.000109	0.000938	CbGpPWpGaD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—ANXA1—stomach cancer	0.000109	0.000937	CbGpPWpGaD
Vidarabine—ADORA2A—Circadian rythm related genes—TYMS—stomach cancer	0.000109	0.000936	CbGpPWpGaD
Vidarabine—Palpitations—Doxorubicin—stomach cancer	0.000108	0.00115	CcSEcCtD
Vidarabine—Anaphylactic shock—Epirubicin—stomach cancer	0.000108	0.00115	CcSEcCtD
Vidarabine—Hypotension—Methotrexate—stomach cancer	0.000108	0.00114	CcSEcCtD
Vidarabine—Loss of consciousness—Doxorubicin—stomach cancer	0.000107	0.00114	CcSEcCtD
Vidarabine—ADA—Metabolism—PLIN2—stomach cancer	0.000107	0.000922	CbGpPWpGaD
Vidarabine—Cough—Doxorubicin—stomach cancer	0.000107	0.00113	CcSEcCtD
Vidarabine—Shock—Epirubicin—stomach cancer	0.000106	0.00113	CcSEcCtD
Vidarabine—Convulsion—Doxorubicin—stomach cancer	0.000106	0.00113	CcSEcCtD
Vidarabine—Dizziness—Docetaxel—stomach cancer	0.000106	0.00112	CcSEcCtD
Vidarabine—Hypertension—Doxorubicin—stomach cancer	0.000105	0.00112	CcSEcCtD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—ADRB1—stomach cancer	0.000105	0.000907	CbGpPWpGaD
Vidarabine—Tachycardia—Epirubicin—stomach cancer	0.000105	0.00112	CcSEcCtD
Vidarabine—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000105	0.00112	CcSEcCtD
Vidarabine—ADA—Metabolism—CA2—stomach cancer	0.000104	0.000897	CbGpPWpGaD
Vidarabine—Hyperhidrosis—Epirubicin—stomach cancer	0.000104	0.00111	CcSEcCtD
Vidarabine—Chest pain—Doxorubicin—stomach cancer	0.000104	0.00111	CcSEcCtD
Vidarabine—Anxiety—Doxorubicin—stomach cancer	0.000104	0.0011	CcSEcCtD
Vidarabine—ADK—Metabolism—ALDOB—stomach cancer	0.000104	0.000891	CbGpPWpGaD
Vidarabine—Paraesthesia—Methotrexate—stomach cancer	0.000103	0.0011	CcSEcCtD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—FYN—stomach cancer	0.000103	0.000887	CbGpPWpGaD
Vidarabine—Discomfort—Doxorubicin—stomach cancer	0.000103	0.00109	CcSEcCtD
Vidarabine—Dyspnoea—Methotrexate—stomach cancer	0.000103	0.00109	CcSEcCtD
Vidarabine—Somnolence—Methotrexate—stomach cancer	0.000102	0.00109	CcSEcCtD
Vidarabine—Dizziness—Capecitabine—stomach cancer	0.000102	0.00109	CcSEcCtD
Vidarabine—Dry mouth—Doxorubicin—stomach cancer	0.000102	0.00108	CcSEcCtD
Vidarabine—ADA—Metabolism—PGAM1—stomach cancer	0.000102	0.000874	CbGpPWpGaD
Vidarabine—ADA—Metabolism—NT5E—stomach cancer	0.000102	0.000874	CbGpPWpGaD
Vidarabine—Vomiting—Docetaxel—stomach cancer	0.000102	0.00108	CcSEcCtD
Vidarabine—Rash—Docetaxel—stomach cancer	0.000101	0.00107	CcSEcCtD
Vidarabine—Hypotension—Epirubicin—stomach cancer	0.000101	0.00107	CcSEcCtD
Vidarabine—Dermatitis—Docetaxel—stomach cancer	0.000101	0.00107	CcSEcCtD
Vidarabine—Headache—Docetaxel—stomach cancer	0.0001	0.00106	CcSEcCtD
Vidarabine—Anaphylactic shock—Doxorubicin—stomach cancer	9.97e-05	0.00106	CcSEcCtD
Vidarabine—ADORA2A—GPCRs, Class A Rhodopsin-like—ADRB2—stomach cancer	9.97e-05	0.000858	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—HBEGF—stomach cancer	9.94e-05	0.000856	CbGpPWpGaD
Vidarabine—Pain—Methotrexate—stomach cancer	9.84e-05	0.00105	CcSEcCtD
Vidarabine—Vomiting—Capecitabine—stomach cancer	9.83e-05	0.00105	CcSEcCtD
Vidarabine—Musculoskeletal discomfort—Epirubicin—stomach cancer	9.81e-05	0.00104	CcSEcCtD
Vidarabine—Shock—Doxorubicin—stomach cancer	9.8e-05	0.00104	CcSEcCtD
Vidarabine—Rash—Capecitabine—stomach cancer	9.75e-05	0.00104	CcSEcCtD
Vidarabine—Dermatitis—Capecitabine—stomach cancer	9.74e-05	0.00104	CcSEcCtD
Vidarabine—Tachycardia—Doxorubicin—stomach cancer	9.73e-05	0.00103	CcSEcCtD
Vidarabine—ADA—Metabolism—ALDH7A1—stomach cancer	9.69e-05	0.000834	CbGpPWpGaD
Vidarabine—ADA—Metabolism—PLCE1—stomach cancer	9.69e-05	0.000834	CbGpPWpGaD
Vidarabine—Headache—Capecitabine—stomach cancer	9.68e-05	0.00103	CcSEcCtD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—FGFR2—stomach cancer	9.68e-05	0.000833	CbGpPWpGaD
Vidarabine—Paraesthesia—Epirubicin—stomach cancer	9.67e-05	0.00103	CcSEcCtD
Vidarabine—Hyperhidrosis—Doxorubicin—stomach cancer	9.63e-05	0.00102	CcSEcCtD
Vidarabine—ADK—Metabolism—ALOX5—stomach cancer	9.62e-05	0.000829	CbGpPWpGaD
Vidarabine—Dyspnoea—Epirubicin—stomach cancer	9.6e-05	0.00102	CcSEcCtD
Vidarabine—Somnolence—Epirubicin—stomach cancer	9.57e-05	0.00102	CcSEcCtD
Vidarabine—ADA—Circadian rythm related genes—JUN—stomach cancer	9.51e-05	0.000819	CbGpPWpGaD
Vidarabine—Nausea—Docetaxel—stomach cancer	9.48e-05	0.00101	CcSEcCtD
Vidarabine—ADK—Metabolism—DPYD—stomach cancer	9.47e-05	0.000815	CbGpPWpGaD
Vidarabine—Hypotension—Doxorubicin—stomach cancer	9.31e-05	0.000991	CcSEcCtD
Vidarabine—ADA—Metabolism—UMPS—stomach cancer	9.29e-05	0.000799	CbGpPWpGaD
Vidarabine—Pain—Epirubicin—stomach cancer	9.21e-05	0.00098	CcSEcCtD
Vidarabine—Nausea—Capecitabine—stomach cancer	9.18e-05	0.000977	CcSEcCtD
Vidarabine—Urticaria—Methotrexate—stomach cancer	9.14e-05	0.000973	CcSEcCtD
Vidarabine—Musculoskeletal discomfort—Doxorubicin—stomach cancer	9.08e-05	0.000966	CcSEcCtD
Vidarabine—ADA—Circadian rythm related genes—MAPK8—stomach cancer	9e-05	0.000775	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—PPP2R1A—stomach cancer	8.99e-05	0.000774	CbGpPWpGaD
Vidarabine—Paraesthesia—Doxorubicin—stomach cancer	8.95e-05	0.000952	CcSEcCtD
Vidarabine—ADORA2A—GPCR ligand binding—AGTR2—stomach cancer	8.91e-05	0.000767	CbGpPWpGaD
Vidarabine—Dyspnoea—Doxorubicin—stomach cancer	8.88e-05	0.000945	CcSEcCtD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—IRS2—stomach cancer	8.86e-05	0.000763	CbGpPWpGaD
Vidarabine—Somnolence—Doxorubicin—stomach cancer	8.86e-05	0.000942	CcSEcCtD
Vidarabine—ADORA2A—GPCR ligand binding—F2R—stomach cancer	8.81e-05	0.000759	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—HRH4—stomach cancer	8.67e-05	0.000747	CbGpPWpGaD
Vidarabine—ADA—Metabolism—PDHA1—stomach cancer	8.63e-05	0.000743	CbGpPWpGaD
Vidarabine—ADA—Metabolism—ECHS1—stomach cancer	8.63e-05	0.000743	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—HTR1A—stomach cancer	8.58e-05	0.000739	CbGpPWpGaD
Vidarabine—Urticaria—Epirubicin—stomach cancer	8.56e-05	0.00091	CcSEcCtD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—ADRB2—stomach cancer	8.54e-05	0.000735	CbGpPWpGaD
Vidarabine—Pain—Doxorubicin—stomach cancer	8.52e-05	0.000907	CcSEcCtD
Vidarabine—Hypersensitivity—Methotrexate—stomach cancer	8.48e-05	0.000902	CcSEcCtD
Vidarabine—ADORA2A—Circadian rythm related genes—CDK4—stomach cancer	8.48e-05	0.00073	CbGpPWpGaD
Vidarabine—ADK—Metabolism—GSTT1—stomach cancer	8.37e-05	0.000721	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—ANXA1—stomach cancer	8.29e-05	0.000713	CbGpPWpGaD
Vidarabine—ADK—Metabolism—CYP2A6—stomach cancer	8.28e-05	0.000713	CbGpPWpGaD
Vidarabine—Asthenia—Methotrexate—stomach cancer	8.26e-05	0.000878	CcSEcCtD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—IL6ST—stomach cancer	8.14e-05	0.000701	CbGpPWpGaD
Vidarabine—ADA—Metabolism—FADS1—stomach cancer	8.12e-05	0.000699	CbGpPWpGaD
Vidarabine—ADA—Metabolism—TYMP—stomach cancer	8.12e-05	0.000699	CbGpPWpGaD
Vidarabine—ADK—Metabolism—AKR1C3—stomach cancer	8.05e-05	0.000693	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—ADRB1—stomach cancer	8.02e-05	0.000691	CbGpPWpGaD
Vidarabine—Hypersensitivity—Epirubicin—stomach cancer	7.93e-05	0.000844	CcSEcCtD
Vidarabine—ADORA2A—Signaling by NGF—FYN—stomach cancer	7.93e-05	0.000683	CbGpPWpGaD
Vidarabine—Urticaria—Doxorubicin—stomach cancer	7.92e-05	0.000842	CcSEcCtD
Vidarabine—ADORA2A—Signaling by GPCR—HRH4—stomach cancer	7.87e-05	0.000678	CbGpPWpGaD
Vidarabine—ADK—Metabolism—ENO1—stomach cancer	7.85e-05	0.000676	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—KISS1—stomach cancer	7.73e-05	0.000665	CbGpPWpGaD
Vidarabine—Asthenia—Epirubicin—stomach cancer	7.73e-05	0.000822	CcSEcCtD
Vidarabine—ADORA2A—Circadian rythm related genes—PPARG—stomach cancer	7.7e-05	0.000663	CbGpPWpGaD
Vidarabine—Dizziness—Methotrexate—stomach cancer	7.61e-05	0.00081	CcSEcCtD
Vidarabine—ADA—Metabolism—SREBF2—stomach cancer	7.6e-05	0.000654	CbGpPWpGaD
Vidarabine—ADA—Metabolism—RORA—stomach cancer	7.51e-05	0.000647	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—FGFR2—stomach cancer	7.44e-05	0.000641	CbGpPWpGaD
Vidarabine—Hypersensitivity—Doxorubicin—stomach cancer	7.34e-05	0.000781	CcSEcCtD
Vidarabine—Vomiting—Methotrexate—stomach cancer	7.32e-05	0.000778	CcSEcCtD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—IL6R—stomach cancer	7.27e-05	0.000626	CbGpPWpGaD
Vidarabine—Rash—Methotrexate—stomach cancer	7.26e-05	0.000772	CcSEcCtD
Vidarabine—Dermatitis—Methotrexate—stomach cancer	7.25e-05	0.000771	CcSEcCtD
Vidarabine—Headache—Methotrexate—stomach cancer	7.21e-05	0.000767	CcSEcCtD
Vidarabine—Asthenia—Doxorubicin—stomach cancer	7.15e-05	0.000761	CcSEcCtD
Vidarabine—Dizziness—Epirubicin—stomach cancer	7.12e-05	0.000758	CcSEcCtD
Vidarabine—ADA—Metabolism—ALDOB—stomach cancer	7.04e-05	0.000606	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—KISS1—stomach cancer	7.02e-05	0.000604	CbGpPWpGaD
Vidarabine—ADK—Metabolism—CD44—stomach cancer	6.96e-05	0.000599	CbGpPWpGaD
Vidarabine—ADORA2A—Circadian rythm related genes—SERPINE1—stomach cancer	6.94e-05	0.000597	CbGpPWpGaD
Vidarabine—Vomiting—Epirubicin—stomach cancer	6.85e-05	0.000728	CcSEcCtD
Vidarabine—Nausea—Methotrexate—stomach cancer	6.84e-05	0.000727	CcSEcCtD
Vidarabine—ADORA2A—Signaling by NGF—IRS2—stomach cancer	6.82e-05	0.000587	CbGpPWpGaD
Vidarabine—Rash—Epirubicin—stomach cancer	6.79e-05	0.000722	CcSEcCtD
Vidarabine—Dermatitis—Epirubicin—stomach cancer	6.78e-05	0.000722	CcSEcCtD
Vidarabine—Headache—Epirubicin—stomach cancer	6.75e-05	0.000718	CcSEcCtD
Vidarabine—ADORA2A—GPCR downstream signaling—GAST—stomach cancer	6.65e-05	0.000572	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—RGS2—stomach cancer	6.65e-05	0.000572	CbGpPWpGaD
Vidarabine—Dizziness—Doxorubicin—stomach cancer	6.59e-05	0.000701	CcSEcCtD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—RHOA—stomach cancer	6.56e-05	0.000565	CbGpPWpGaD
Vidarabine—ADA—Metabolism—ALOX5—stomach cancer	6.54e-05	0.000563	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—ADRB2—stomach cancer	6.5e-05	0.00056	CbGpPWpGaD
Vidarabine—ADA—Metabolism—DPYD—stomach cancer	6.44e-05	0.000554	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—GLI3—stomach cancer	6.43e-05	0.000554	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—KISS1R—stomach cancer	6.43e-05	0.000554	CbGpPWpGaD
Vidarabine—Nausea—Epirubicin—stomach cancer	6.4e-05	0.000681	CcSEcCtD
Vidarabine—Vomiting—Doxorubicin—stomach cancer	6.34e-05	0.000674	CcSEcCtD
Vidarabine—Rash—Doxorubicin—stomach cancer	6.28e-05	0.000668	CcSEcCtD
Vidarabine—ADA—Circadian rythm related genes—TP53—stomach cancer	6.28e-05	0.000541	CbGpPWpGaD
Vidarabine—Dermatitis—Doxorubicin—stomach cancer	6.28e-05	0.000668	CcSEcCtD
Vidarabine—ADORA2A—Signaling by NGF—IL6ST—stomach cancer	6.26e-05	0.000539	CbGpPWpGaD
Vidarabine—Headache—Doxorubicin—stomach cancer	6.24e-05	0.000664	CcSEcCtD
Vidarabine—ADORA2A—Signaling Pathways—RBP1—stomach cancer	6.14e-05	0.000528	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—ERBB2—stomach cancer	6.08e-05	0.000523	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—RGS2—stomach cancer	6.03e-05	0.00052	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—GAST—stomach cancer	6.03e-05	0.00052	CbGpPWpGaD
Vidarabine—Nausea—Doxorubicin—stomach cancer	5.92e-05	0.00063	CcSEcCtD
Vidarabine—ADK—Metabolism—PPP2R1A—stomach cancer	5.92e-05	0.000509	CbGpPWpGaD
Vidarabine—ADK—Metabolism—GSTP1—stomach cancer	5.8e-05	0.0005	CbGpPWpGaD
Vidarabine—ADA—Circadian rythm related genes—IL6—stomach cancer	5.75e-05	0.000495	CbGpPWpGaD
Vidarabine—ADK—Metabolism—HMOX1—stomach cancer	5.72e-05	0.000493	CbGpPWpGaD
Vidarabine—ADA—Metabolism—GSTT1—stomach cancer	5.69e-05	0.00049	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—CDKN1B—stomach cancer	5.63e-05	0.000485	CbGpPWpGaD
Vidarabine—ADA—Metabolism—CYP2A6—stomach cancer	5.63e-05	0.000484	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—IL6R—stomach cancer	5.59e-05	0.000481	CbGpPWpGaD
Vidarabine—DPP4—Metabolism of proteins—MMP2—stomach cancer	5.55e-05	0.000478	CbGpPWpGaD
Vidarabine—ADA—Metabolism—AKR1C3—stomach cancer	5.47e-05	0.000471	CbGpPWpGaD
Vidarabine—ADORA2A—Circadian rythm related genes—JUN—stomach cancer	5.46e-05	0.00047	CbGpPWpGaD
Vidarabine—ADK—Metabolism—TYMS—stomach cancer	5.4e-05	0.000465	CbGpPWpGaD
Vidarabine—ADK—Metabolism—GSTM1—stomach cancer	5.33e-05	0.000459	CbGpPWpGaD
Vidarabine—ADA—Metabolism—ENO1—stomach cancer	5.33e-05	0.000459	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—CDKN1A—stomach cancer	5.19e-05	0.000447	CbGpPWpGaD
Vidarabine—ADORA2A—Circadian rythm related genes—MAPK8—stomach cancer	5.17e-05	0.000445	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—RHOA—stomach cancer	5.05e-05	0.000435	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—AGTR2—stomach cancer	5.04e-05	0.000434	CbGpPWpGaD
Vidarabine—ADK—Metabolism—ERCC2—stomach cancer	5.01e-05	0.000432	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—WWOX—stomach cancer	5e-05	0.000431	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—F2R—stomach cancer	4.98e-05	0.000429	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—HTR1A—stomach cancer	4.85e-05	0.000417	CbGpPWpGaD
Vidarabine—ADA—Metabolism—CD44—stomach cancer	4.73e-05	0.000407	CbGpPWpGaD
Vidarabine—ADK—Metabolism—MTHFR—stomach cancer	4.71e-05	0.000406	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—ANXA1—stomach cancer	4.68e-05	0.000403	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—ERBB2—stomach cancer	4.67e-05	0.000402	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—WIF1—stomach cancer	4.65e-05	0.0004	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—HRH4—stomach cancer	4.65e-05	0.0004	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—STAT3—stomach cancer	4.63e-05	0.000399	CbGpPWpGaD
Vidarabine—DPP4—Metabolism of proteins—CXCL8—stomach cancer	4.61e-05	0.000397	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—AGTR2—stomach cancer	4.57e-05	0.000394	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—ADRB1—stomach cancer	4.53e-05	0.00039	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—F2R—stomach cancer	4.52e-05	0.000389	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—MAPK3—stomach cancer	4.43e-05	0.000381	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—HTR1A—stomach cancer	4.4e-05	0.000379	CbGpPWpGaD
Vidarabine—ADK—Metabolism—CAV1—stomach cancer	4.35e-05	0.000374	CbGpPWpGaD
Vidarabine—ADK—Metabolism—APOA1—stomach cancer	4.34e-05	0.000373	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—CDKN1B—stomach cancer	4.33e-05	0.000373	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PRKAB1—stomach cancer	4.29e-05	0.00037	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—ANXA1—stomach cancer	4.25e-05	0.000366	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—MAPK1—stomach cancer	4.21e-05	0.000363	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—EGFR—stomach cancer	4.21e-05	0.000363	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—RNF43—stomach cancer	4.15e-05	0.000357	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—KISS1—stomach cancer	4.15e-05	0.000357	CbGpPWpGaD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—stomach cancer	4.12e-05	0.000355	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—ADRB1—stomach cancer	4.12e-05	0.000355	CbGpPWpGaD
Vidarabine—ADA—Metabolism—PPP2R1A—stomach cancer	4.02e-05	0.000346	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—CDKN1A—stomach cancer	3.99e-05	0.000344	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—KRAS—stomach cancer	3.98e-05	0.000343	CbGpPWpGaD
Vidarabine—ADA—Metabolism—GSTP1—stomach cancer	3.94e-05	0.00034	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—MAPK8—stomach cancer	3.9e-05	0.000336	CbGpPWpGaD
Vidarabine—ADA—Metabolism—HMOX1—stomach cancer	3.89e-05	0.000335	CbGpPWpGaD
Vidarabine—ADK—Metabolism—PPARG—stomach cancer	3.82e-05	0.000329	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—FST—stomach cancer	3.7e-05	0.000318	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—ADRB2—stomach cancer	3.67e-05	0.000316	CbGpPWpGaD
Vidarabine—ADA—Metabolism—TYMS—stomach cancer	3.67e-05	0.000316	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—PIK3CA—stomach cancer	3.66e-05	0.000315	CbGpPWpGaD
Vidarabine—ADA—Metabolism—GSTM1—stomach cancer	3.63e-05	0.000312	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—HBEGF—stomach cancer	3.62e-05	0.000311	CbGpPWpGaD
Vidarabine—ADORA2A—Circadian rythm related genes—TP53—stomach cancer	3.61e-05	0.000311	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—RGS2—stomach cancer	3.57e-05	0.000307	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—GAST—stomach cancer	3.57e-05	0.000307	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—STAT3—stomach cancer	3.56e-05	0.000307	CbGpPWpGaD
Vidarabine—ADK—Metabolism—ALB—stomach cancer	3.44e-05	0.000296	CbGpPWpGaD
Vidarabine—ADA—Metabolism—ERCC2—stomach cancer	3.41e-05	0.000293	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—MAPK3—stomach cancer	3.41e-05	0.000293	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—HRAS—stomach cancer	3.38e-05	0.000291	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—FGG—stomach cancer	3.38e-05	0.000291	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—ADRB2—stomach cancer	3.34e-05	0.000287	CbGpPWpGaD
Vidarabine—ADORA2A—Circadian rythm related genes—IL6—stomach cancer	3.3e-05	0.000284	CbGpPWpGaD
Vidarabine—ADK—Metabolism—NOS3—stomach cancer	3.29e-05	0.000283	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—PPP2R1A—stomach cancer	3.27e-05	0.000282	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PRKAA1—stomach cancer	3.25e-05	0.00028	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—MAPK1—stomach cancer	3.24e-05	0.000279	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—EGFR—stomach cancer	3.24e-05	0.000279	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—IL6—stomach cancer	3.24e-05	0.000279	CbGpPWpGaD
Vidarabine—ADA—Metabolism—MTHFR—stomach cancer	3.2e-05	0.000276	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—RBP4—stomach cancer	3.14e-05	0.000271	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—CXCL8—stomach cancer	3.14e-05	0.00027	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—KRAS—stomach cancer	3.06e-05	0.000263	CbGpPWpGaD
Vidarabine—ADK—Metabolism—PTGS2—stomach cancer	3.01e-05	0.000259	CbGpPWpGaD
Vidarabine—ADA—Metabolism—CAV1—stomach cancer	2.96e-05	0.000254	CbGpPWpGaD
Vidarabine—ADA—Metabolism—APOA1—stomach cancer	2.95e-05	0.000254	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—PIK3CA—stomach cancer	2.81e-05	0.000242	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—HSPB1—stomach cancer	2.7e-05	0.000233	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—AGTR2—stomach cancer	2.7e-05	0.000233	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—BMP2—stomach cancer	2.67e-05	0.00023	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—F2R—stomach cancer	2.67e-05	0.00023	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—AKR1C3—stomach cancer	2.63e-05	0.000226	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—HRAS—stomach cancer	2.6e-05	0.000224	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—HTR1A—stomach cancer	2.6e-05	0.000224	CbGpPWpGaD
Vidarabine—ADA—Metabolism—PPARG—stomach cancer	2.6e-05	0.000224	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—PRKCB—stomach cancer	2.52e-05	0.000217	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—ANXA1—stomach cancer	2.51e-05	0.000216	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—IL6—stomach cancer	2.49e-05	0.000214	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—ADRB1—stomach cancer	2.43e-05	0.000209	CbGpPWpGaD
Vidarabine—ADA—Metabolism—ALB—stomach cancer	2.34e-05	0.000201	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—RPS6—stomach cancer	2.32e-05	0.0002	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—PRKCB—stomach cancer	2.29e-05	0.000197	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—IL6ST—stomach cancer	2.28e-05	0.000196	CbGpPWpGaD
Vidarabine—ADA—Metabolism—NOS3—stomach cancer	2.23e-05	0.000192	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—HBEGF—stomach cancer	2.14e-05	0.000184	CbGpPWpGaD
Vidarabine—ADA—Metabolism—PTGS2—stomach cancer	2.04e-05	0.000176	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—IL6R—stomach cancer	2.03e-05	0.000175	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—RHOA—stomach cancer	2.02e-05	0.000174	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—ADRB2—stomach cancer	1.97e-05	0.00017	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PPP2R1A—stomach cancer	1.93e-05	0.000166	CbGpPWpGaD
Vidarabine—ADK—Metabolism—PIK3CA—stomach cancer	1.85e-05	0.000159	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—RHOA—stomach cancer	1.84e-05	0.000158	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—SMAD4—stomach cancer	1.79e-05	0.000154	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—CXCL8—stomach cancer	1.77e-05	0.000153	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—FYN—stomach cancer	1.7e-05	0.000147	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—CXCL8—stomach cancer	1.61e-05	0.000139	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—FGFR2—stomach cancer	1.6e-05	0.000138	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—IRS2—stomach cancer	1.46e-05	0.000126	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CAV1—stomach cancer	1.42e-05	0.000122	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—APOA1—stomach cancer	1.42e-05	0.000122	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PRKCB—stomach cancer	1.35e-05	0.000116	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—IL6ST—stomach cancer	1.35e-05	0.000116	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—APC—stomach cancer	1.29e-05	0.000111	CbGpPWpGaD
Vidarabine—ADA—Metabolism—PIK3CA—stomach cancer	1.26e-05	0.000108	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—MAPK3—stomach cancer	1.24e-05	0.000107	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—IL6R—stomach cancer	1.2e-05	0.000103	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—MAPK1—stomach cancer	1.18e-05	0.000101	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—EGFR—stomach cancer	1.18e-05	0.000101	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—PIK3CA—stomach cancer	1.13e-05	9.69e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—SERPINE1—stomach cancer	1.12e-05	9.68e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—KRAS—stomach cancer	1.11e-05	9.58e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—RHOA—stomach cancer	1.08e-05	9.34e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—NOS3—stomach cancer	1.07e-05	9.24e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—PIK3CA—stomach cancer	1.02e-05	8.8e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—ERBB2—stomach cancer	1e-05	8.64e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CXCL8—stomach cancer	9.52e-06	8.2e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—HRAS—stomach cancer	9.46e-06	8.14e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CDKN1B—stomach cancer	9.3e-06	8e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—IL6—stomach cancer	9.05e-06	7.79e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CCND1—stomach cancer	8.87e-06	7.64e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—JUN—stomach cancer	8.85e-06	7.62e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—MMP9—stomach cancer	8.61e-06	7.41e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CDKN1A—stomach cancer	8.58e-06	7.39e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—MAPK8—stomach cancer	8.37e-06	7.21e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—VEGFA—stomach cancer	7.73e-06	6.66e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—STAT3—stomach cancer	7.66e-06	6.59e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—MAPK3—stomach cancer	7.31e-06	6.3e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—MYC—stomach cancer	7.11e-06	6.12e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—MAPK1—stomach cancer	6.96e-06	5.99e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—EGFR—stomach cancer	6.96e-06	5.99e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—KRAS—stomach cancer	6.57e-06	5.66e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PIK3CA—stomach cancer	6.04e-06	5.2e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—TP53—stomach cancer	5.84e-06	5.03e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—HRAS—stomach cancer	5.59e-06	4.81e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—IL6—stomach cancer	5.35e-06	4.6e-05	CbGpPWpGaD
